FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Pledge Party

  • Home
  •  | 
  • Tag Archives: "Pledge Party"

Namaste signs binding terms sheet to acquire UK-based licensed pharmaceutical distribution company AF Trading Ltd.

Namaste signs binding terms sheet to acquire UK-based licensed pharmaceutical distribution company AF Trading Ltd.
Sept. 13, 2018 /CNW/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company's wholly-owned subsidiary, Namaste Bahamas Inc. ("Namaste Bahamas"), has signed a Binding Terms Sheet ("Terms Sheet") to acquire all of the issued and outstanding shares of UK-Based AF Trading Ltd. (operating as "Access Fulfillment" or "accessfulfilment.com"). Access Fulfillment operates a 30,000 square-foot distribution facility in the UK and holds a Wholesale Distribution Authorization (Human) License issued by the Medicines and Healthcare Products Regulatory Agency ("MHRA") which allows Access Fulfillment to distribute pharmaceutical products throughout the UK. The acquisition of Access Fulfillment is the first step in Namaste developing its future medical cannabis distribution platform in the UK, which represents a much larger customer base than that of its Canadian operations. The Company intends to launch a platform similar to its Canadian wholly-owned subsidiary Cannmart Inc. ("Cannmart") within the UK market to help monetize on its database of over 500,000 customers.
Read more

Namaste provides update on Share Pledge Party and reaffirms its intention to list the company on the NASDAQ Exchange

Namaste provides update on Share Pledge Party and reaffirms its intention to list the company on the NASDAQ Exchange
Sept. 11, 2018 /CNW/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that further to its July 23rd news release, the Company intends to continue to pursue the listing of its common shares on the NASDAQ Capital Market ("NASDAQ"). Due to Company developments and a recent increase in its share price, the Company is now closer to meeting the requirements to list on NASDAQ. Based on the Company's current share price, and the anticipated increase in sales through the launch of its Access to Cannabis for Medical Purposes Regulations ("ACMPR") sales license, the Company currently intends on reaching the share-price target organically without any share consolidation.
Read more